Prevalence and Clinical Significance of Skin Manifestations in Parkinson Disease Patients

Prevalence and Clinical Significance of Skin Manifestations in Parkinson Disease Patients

Authors

  • Ayşegül Yalçınkaya Iyidal Department of Dermatology, Ankara Bilkent City Hospital, Çankaya/Ankara, Türkiye
  • Funda Erduran Department of Dermatology, Ankara Bilkent City Hospital, 06800, Çankaya/Ankara, Türkiye
  • Yıldız Hayran Department of Dermatology, Ankara Bilkent City Hospital, 06800, Çankaya/Ankara, Türkiye
  • Yeşim Sücüllü Karadağ Department of Neurology, Ankara Bilkent City Hospital, 06800, Çankaya/Ankara, Türkiye

Keywords:

Parkinson's Disease, Dermatological Manifestations, Seborrheic Dermatitis, Xerosis, Hyperhidrosis

Abstract

Background: Parkinson's disease (PD) is primarily characterized by motor symptoms, but non-motor symptoms, including skin manifestations, are increasingly recognized. These remain underexplored despite their potential impact on quality of life.

Objectives: This study aimed to evaluate the prevalence and clinical features of skin findings in PD patients, with a focus on identifying potential pathogenetic links between dermatological conditions and PD.

Methods: A total of 215 PD patients were included. Comprehensive dermatological examinations were performed, and demographic and clinical data were collected. Statistical analysis was conducted using SPSS 23.0, with significance set at P < 0.05.

Results: Skin conditions were found in 92.1% of PD patients. Xerosis, seborrheic dermatitis, and hyperhidrosis were the most common findings. Pre-PD xerosis was associated with an earlier stage of PD (P = 0.001). Use of PD medications, such as levodopa/carbidopa/entacapone, was linked to a lower incidence of seborrheic dermatitis (P = 0.040). A significant correlation was also noted between rosacea and cherry angioma (P = 0.01).

Conclusion: Dermatological conditions are prevalent in PD and may precede its motor symptoms. Skin assessments could aid early diagnosis and management of PD, highlighting the need for further research on their pathogenetic mechanisms.

Author Biographies

Yıldız Hayran, Department of Dermatology, Ankara Bilkent City Hospital, 06800, Çankaya/Ankara, Türkiye

Associate Professor

Yeşim Sücüllü Karadağ, Department of Neurology, Ankara Bilkent City Hospital, 06800, Çankaya/Ankara, Türkiye

Professor

References

Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87-92. DOI:10.2147/CCID.S130319

Shah P, Sagar PR, Alhumaidi N, Bollampally VC, Malik BH. Parkinson’s Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis? Cureus. 2020;12(8):e9933. DOI:10.7759/cureus.9933

Shahid W, Satyjeet F, Kumari R, et al. Dermatological Manifestations of Parkinson’s Disease: Clues for Diagnosis. Cureus. 2020;12(10):e10836. DOI:10.7759/cureus.10836

Tomic S, Kuric I, Kuric TG, et al. Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson’s Disease. J Clin Neurol. 2022;18(6):628-634. DOI:10.3988/jcn.2022.18.6.628

Dinesh D, Lee JS, Gao X, Palacios N. Skin conditions in early Parkinson’s disease. Parkinsonism Relat Disord. 2021;84:40-46. DOI:10.1016/j.parkreldis.2021.01.018

Skorvanek M, Bhatia KP. The Skin and Parkinson’s Disease: Review of Clinical, Diagnostic, and Therapeutic Issues. Mov Disord Clin Pract. 2017;4(1):21-31. DOI:10.1002/mdc3.12425

Niemann N, Billnitzer A, Jankovic J. Parkinson’s disease and skin. Parkinsonism Relat Disord. 2021;82:61-76. DOI:10.1016/j.parkreldis.2020.11.017

Mathieu RJ, Guido N, Ibler E, et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2018;32(4):e141-e144. DOI:10.1111/jdv.14638

van Wamelen DJ, Leta V, Podlewska AM, et al. Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease. J Neurol. 2019;266(7):1736-1742. DOI:10.1007/s00415-019-09325-w

Scott GD, Lim MM, Drake MG, Woltjer R, Quinn JF. Onset of Skin, Gut, and Genitourinary Prodromal Parkinson’s Disease: A Study of 1.5 Million Veterans. Mov Disord. 2021;36(9):2094-2103. DOI:10.1002/mds.28636

Jucevičiūtė N, Banaitytė I, Vaitkus A, Balnytė R. Preclinical signs of Parkinson’s disease: A possible association of Parkinson’s disease with skin and hair features. Med Hypotheses. 2019;127:100-104. DOI:10.1016/j.mehy.2019.04.013

Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X. Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants. BMJ Open. 2021;11(7):e046329. DOI:10.1136/bmjopen-2020-046329

Han Y, Wu D, Wang Y, Xie J, Zhang Z. Skin alpha-synuclein deposit patterns: A predictor of Parkinson’s disease subtypes. EBioMedicine. 2022;80:104076. DOI:10.1016/j.ebiom.2022.104076

Rodríguez-Leyva I, Calderón-Garcidueñas AL, Jiménez-Capdeville ME, et al. α-Synuclein inclusions in the skin of Parkinson’s disease and parkinsonism. Ann Clin Transl Neurol. 2014;1(7):471-478. DOI:10.1002/acn3.78

Wakabayashi K. Where and how alpha-synuclein pathology spreads in Parkinson’s disease. Neuropathology. 2020;40(5):415-425. DOI:10.1111/neup.12691

Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord. 2015;30(2):229-237. DOI:10.1002/mds.26077

Martignoni E, Godi L, Pacchetti C, et al. Is seborrhea a sign of autonomic impairment in Parkinson’s disease? J Neural Transm. 1997;104(11-12):1295-1304. DOI:10.1007/BF01294730

Arsic Arsenijevic VS, Milobratovic D, Barac AM, Vekic B, Marinkovic J, Kostic VS. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5. DOI:10.1186/1471-5945-14-5

Kohn SR, Pochi PE, Strauss JS, Sax DS, Feldman RG, Timberlake WH. Sebaceous gland secretion in Parkinson’s disease during L-dopa treatment. J Invest Dermatol. 1973;60(3). DOI:10.1111/1523-1747.ep12682040

Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study. JAMA Neurol. 2016;73(5):529-534. DOI:10.1001/jamaneurol.2016.0022

Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in Parkinson’s disease. J Neural Transm. 2001;108(2):205-213. DOI:10.1007/s007020170088

Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625-639. DOI:10.1016/S1474-4422(15)00007-1

Ferreira J, Silva JM, Freire R, et al. Skin cancers and precancerous lesions in Parkinson’s disease patients. Mov Disord. 2007;22(10):1471-1475. DOI:10.1002/mds.21575

Yaldiz M. Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic. Medicine (Baltimore). 2019;98(28):e16465. DOI:10.1097/MD.0000000000016465.

Downloads

Published

2024-10-30

How to Cite

1.
Prevalence and Clinical Significance of Skin Manifestations in Parkinson Disease Patients. Dermatol Pract Concept [Internet]. 2024 Oct. 30 [cited 2024 Nov. 7];14(4):e2024241. Available from: https://dpcj.org/index.php/dpc/article/view/4372

Share